grant

Molecular Phenotyping of ARDS, Pneumonia, and Sepsis using Latent Class Analysis and Metagenomic Sequencing

Organization UNIVERSITY OF CALIFORNIA, SAN FRANCISCOLocation SAN FRANCISCO, UNITED STATESPosted 1 May 2023Deadline 30 Apr 2029
NIHUS FederalResearch GrantFY202621+ years oldARDSActive Follow-upAcute Respiratory DistressAcute Respiratory Distress SyndromeAddressAdultAdult ARDSAdult HumanAdult RDSAdult Respiratory Distress SyndromeAreaAsthmaBiologicalBloodBlood Reticuloendothelial SystemBreast CancerBronchial AsthmaCaliforniaCancersClassificationClinicalClinical DataClinical ResearchClinical StudyClinical TrialsCollectionConduct Clinical TrialsCritical CareCritical IllnessCritically IllDa Nang LungDataData SetDevelopmentDiagnosisDiagnosticDrug TherapyEnrollmentFailureFunctional MetagenomicsFutureGeneral HospitalsGeneral TaxonomyGoalsHR positiveHeterogeneityHistoryInflammatoryIntervention TrialInterventional trialInvestigatorsKnowledgeLeadLeadershipLong-term cohort studyLongitudinal cohort studyMalignant Breast NeoplasmMalignant NeoplasmsMalignant TumorMechanical ventilationMetagenomicsMicrobeMorbidityNHLBINational Heart, Lung, and Blood InstituteObservational StudyOut-patientsOutcomeOutpatientsParticipantPathway interactionsPatient outcomePatient-Centered OutcomesPatient-Focused OutcomesPatientsPb elementPharmacological TreatmentPharmacotherapyPhenotypePlasma ProteinsPneumoniaPopulationPopulation HeterogeneityProspective StudiesRecording of previous eventsResearch PersonnelResearchersSamplingSan FranciscoSeaSepsisShock LungSiteStiff lungSurvivorsSyndromeSystematicsTamoxifenTaxonomyTherapeuticTracheaTrachea ProperUniversitiesWorkactive followupadulthoodaspiratebiologicbiological heterogeneityclinical centerclinical databaseclinical heterogeneitycohortdesigndesigningdevelopmentaldiagnostic criteriadiverse populationsdrug interventiondrug treatmentenrollfollow upfollow-upfollowed upfollowupheavy metal Pbheavy metal leadheterogeneous populationhigh definitionhigh-resolutionhistorieshormone receptor +hormone receptor-positiveimprovedimproved outcomeinsightmalignancymalignant breast tumormechanical respiratory assistmechanically ventilatedmetagenome sequencingmetagenomic sequencingmicrobialmicrobiomemolecular phenotypemortalityneoplasm/cancernew drug treatmentsnew drugsnew pharmacological therapeuticnew therapeuticsnew therapynext generation therapeuticsnovelnovel drug treatmentsnovel drugsnovel pharmaco-therapeuticnovel pharmacological therapeuticnovel therapeuticsnovel therapyobservational cohort studyobservational research studyobservational surveypathogenpathwaypatient oriented outcomespatient populationpharmaceutical interventionpharmacological interventionpharmacological therapypharmacology interventionpharmacology treatmentpharmacotherapeuticspopulation diversityprecision medicineprecision-based medicineprognosticprognostic abilityprognostic powerprognostic utilityprognostic valueprospectiveprospective research studyprospective surveyprotein biomarkersprotein markersresponse to therapyresponse to treatmenttargeted drug therapytargeted drug treatmentstargeted therapeutictargeted therapeutic agentstargeted therapytargeted treatmenttherapeutic responsetherapeutic targettherapy responsetraittreatment responsetreatment responsivenesswet lungwindpipe
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

ABSTRACT
This application to RFA HL-23-001 proposes a California Clinical Center for participation in the Acute

Respiratory Distress Syndrome (ARDS), Pneumonia, and Sepsis (APS) Consortium study. Our Clinical Center

consists of 4 sites: University of California, San Francisco (UCSF; lead site); UCSF Fresno; Zuckerberg San

Francisco General…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
Molecular Phenotyping of ARDS, Pneumonia, and Sepsis using Latent Class Analysis and Metagenomic Sequencing — UNIVERSITY | Dev Procure